| Year |
Citation |
Score |
| 2023 |
Angelakos CC, Girven KS, Liu Y, Gonzalez OC, Murphy KR, Jennings KJ, Giardino WJ, Zweifel LS, Suko A, Palmiter RD, Clark SD, Krasnow MA, Bruchas MR, de Lecea L. A cluster of neuropeptide S neurons regulates breathing and arousal. Current Biology : Cb. PMID 38056461 DOI: 10.1016/j.cub.2023.11.018 |
0.398 |
|
| 2023 |
Huang Y, Wojciechowski A, Feldman K, Ettaro R, Veros K, Ritter M, Carvalho Costa P, DiStasio J, Peirick JJ, Reissner KJ, Runyon SP, Clark SD. RTI-263, a biased neuropeptide S receptor agonist that retains an anxiolytic effect, attenuates cocaine-seeking behavior in rats. Neuropharmacology. 241: 109743. PMID 37820934 DOI: 10.1016/j.neuropharm.2023.109743 |
0.351 |
|
| 2019 |
Ettaro R, Markovic T, Daniels D, MacLaren DA, Clark SD. Microinjection of Urotensin II into the Pedunculopontine Tegmentum Leads to an Increase in the Consumption of Sweet Tastants. Physiology & Behavior. 112775. PMID 31843472 DOI: 10.1016/J.Physbeh.2019.112775 |
0.364 |
|
| 2018 |
MacLaren DAA, Ljungberg TL, Griffin ME, Clark SD. Pedunculopontine Tegmentum Cholinergic Loss Leads to a Progressive Decline in Motor Abilities and Neuropathological Changes Resembling Progressive Supranuclear Palsy. The European Journal of Neuroscience. PMID 30339310 DOI: 10.1111/Ejn.14212 |
0.335 |
|
| 2017 |
Clark SD, Kenakin TP, Gertz S, Hassler C, Gay EA, Langston TL, Reinscheid RK, Runyon SP. Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation. Neuropharmacology. PMID 28267583 DOI: 10.1016/J.Neuropharm.2017.03.001 |
0.645 |
|
| 2016 |
Santollo J, Marshall A, Curtis KS, Speth RC, Clark SD, Daniels D. Divergent effects of ERα and ERβ on fluid intake by female rats are not dependent on concomitant changes in AT1R expression or body weight. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. ajpregu.00102.2016. PMID 27122368 DOI: 10.1152/Ajpregu.00102.2016 |
0.352 |
|
| 2015 |
Bensaid M, Michel PP, Clark SD, Hirsch EC, François C. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease. Experimental Neurology. PMID 26571193 DOI: 10.1016/J.Expneurol.2015.11.004 |
0.346 |
|
| 2015 |
Likhite N, Jackson CA, Liang MS, Krzyzanowski MC, Lei P, Wood JF, Birkaya B, Michaels KL, Andreadis ST, Clark SD, Yu MC, Ferkey DM. The protein arginine methyltransferase PRMT5 promotes D2-like dopamine receptor signaling. Science Signaling. 8: ra115. PMID 26554819 DOI: 10.1126/Scisignal.Aad0872 |
0.324 |
|
| 2015 |
MacLaren DA, Markovic T, Daniels D, Clark SD. Enhanced consumption of salient solutions following pedunculopontine tegmental lesions. Neuroscience. 284: 381-99. PMID 25305665 DOI: 10.1016/J.Neuroscience.2014.09.075 |
0.326 |
|
| 2015 |
Mueller LE, Kausch MA, Markovic T, MacLaren DA, Dietz DM, Park J, Clark SD. Intra-ventral tegmental area microinjections of urotensin II modulate the effects of cocaine. Behavioural Brain Research. 278: 271-9. PMID 25264578 DOI: 10.1016/J.Bbr.2014.09.036 |
0.328 |
|
| 2015 |
Cyr M, Parent MJ, Mechawar N, Rosa-Neto P, Soucy JP, Clark SD, Aghourian M, Bedard MA. Deficit in sustained attention following selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as measured with both post-mortem immunocytochemistry and in vivo PET imaging with [¹⁸F]fluoroethoxybenzovesamicol. Behavioural Brain Research. 278: 107-14. PMID 25257103 DOI: 10.1016/J.Bbr.2014.09.021 |
0.321 |
|
| 2014 |
MacLaren DA, Markovic T, Clark SD. Assessment of sensorimotor gating following selective lesions of cholinergic pedunculopontine neurons. The European Journal of Neuroscience. 40: 3526-37. PMID 25208852 DOI: 10.1111/Ejn.12716 |
0.341 |
|
| 2014 |
MacLaren DA, Santini JA, Russell AL, Markovic T, Clark SD. Deficits in motor performance after pedunculopontine lesions in rats--impairment depends on demands of task. The European Journal of Neuroscience. 40: 3224-36. PMID 24995993 DOI: 10.1111/Ejn.12666 |
0.307 |
|
| 2013 |
Grabli D, Karachi C, Folgoas E, Monfort M, Tande D, Clark S, Civelli O, Hirsch EC, François C. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 11986-93. PMID 23864685 DOI: 10.1523/Jneurosci.1568-13.2013 |
0.523 |
|
| 2011 |
Clark SD, Duangdao DM, Schulz S, Zhang L, Liu X, Xu YL, Reinscheid RK. Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry. The Journal of Comparative Neurology. 519: 1867-93. PMID 21452235 DOI: 10.1002/Cne.22606 |
0.718 |
|
| 2011 |
Okamura N, Garau C, Duangdao DM, Clark SD, Jüngling K, Pape HC, Reinscheid RK. Neuropeptide S enhances memory during the consolidation phase and interacts with noradrenergic systems in the brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 744-52. PMID 21150909 DOI: 10.1038/Npp.2010.207 |
0.631 |
|
| 2010 |
Si W, Aluisio L, Okamura N, Clark SD, Fraser I, Sutton SW, Bonaventure P, Reinscheid RK. Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex. Journal of Neurochemistry. 115: 475-82. PMID 20722970 DOI: 10.1111/J.1471-4159.2010.06947.X |
0.656 |
|
| 2010 |
Clark SD, Tran HT, Zeng J, Reinscheid RK. Importance of extracellular loop one of the neuropeptide S receptor for biogenesis and function. Peptides. 31: 130-8. PMID 19874863 DOI: 10.1016/J.Peptides.2009.10.015 |
0.641 |
|
| 2010 |
Gill RS, Hsiung MS, Sum CS, Lavine N, Clark SD, Van Tol HH. The dopamine D4 receptor activates intracellular platelet-derived growth factor receptor beta to stimulate ERK1/2. Cellular Signalling. 22: 285-90. PMID 19782129 DOI: 10.1016/J.Cellsig.2009.09.031 |
0.325 |
|
| 2009 |
Duangdao DM, Clark SD, Okamura N, Reinscheid RK. Behavioral phenotyping of neuropeptide S receptor knockout mice. Behavioural Brain Research. 205: 1-9. PMID 19646487 DOI: 10.1016/J.Bbr.2009.07.024 |
0.649 |
|
| 2009 |
Nagasaki H, Chung S, Dooley CT, Wang Z, Li C, Saito Y, Clark SD, Houghten RA, Civelli O. The pharmacological properties of a novel MCH1 receptor antagonist isolated from combinatorial libraries. European Journal of Pharmacology. 602: 194-202. PMID 19041642 DOI: 10.1016/J.Ejphar.2008.10.068 |
0.643 |
|
| 2008 |
Jüngling K, Seidenbecher T, Sosulina L, Lesting J, Sangha S, Clark SD, Okamura N, Duangdao DM, Xu YL, Reinscheid RK, Pape HC. Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala. Neuron. 59: 298-310. PMID 18667157 DOI: 10.1515/Nf-2008-0405 |
0.726 |
|
| 2007 |
Clark SD, Alderson HL, Winn P, Latimer MP, Nothacker HP, Civelli O. Fusion of diphtheria toxin and urotensin II produces a neurotoxin selective for cholinergic neurons in the rat mesopontine tegmentum. Journal of Neurochemistry. 102: 112-20. PMID 17419804 DOI: 10.1111/J.1471-4159.2007.04529.X |
0.571 |
|
| 2005 |
Nothacker HP, Clark S. From heart to mind: The urotensin II system and its evolving neurophysiological role Febs Journal. 272: 5694-5702. PMID 16279935 DOI: 10.1111/J.1742-4658.2005.04983.X |
0.327 |
|
| 2005 |
Clark SD, Nothacker HP, Blaha CD, Tyler CJ, Duangdao DM, Grupke SL, Helton DR, Leonard CS, Civelli O. Urotensin II acts as a modulator of mesopontine cholinergic neurons. Brain Research. 1059: 139-48. PMID 16183039 DOI: 10.1016/J.Brainres.2005.08.026 |
0.591 |
|
| 2005 |
Huitron-Resendiz S, Kristensen MP, Sánchez-Alavez M, Clark SD, Grupke SL, Tyler C, Suzuki C, Nothacker HP, Civelli O, Criado JR, Henriksen SJ, Leonard CS, de Lecea L. Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5465-74. PMID 15944374 DOI: 10.1523/Jneurosci.4501-04.2005 |
0.568 |
|
| 2005 |
Van Craenenbroeck K, Clark SD, Cox MJ, Oak JN, Liu F, Van Tol HH. Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis. The Journal of Biological Chemistry. 280: 19350-7. PMID 15755724 DOI: 10.1074/Jbc.M414043200 |
0.342 |
|
| 2004 |
Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, Brucher FA, Zeng J, Ly NK, Henriksen SJ, de Lecea L, Civelli O. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron. 43: 487-97. PMID 15312648 DOI: 10.1016/J.Neuron.2004.08.005 |
0.734 |
|
| 2002 |
Civelli O, Reinscheid R, Wang Z, Saito Y, Lin S, Clark S, Nagasaki H, Takahashi T, Nothacker H. The orphan GPCRs: Targets of the future neuropsychopharmacological drugs European Neuropsychopharmacology. 12: 115. DOI: 10.1016/S0924-977X(02)80052-9 |
0.612 |
|
| 2001 |
Clark SD, Nothacker HP, Wang Z, Saito Y, Leslie FM, Civelli O. The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat. Brain Research. 923: 120-7. PMID 11743979 DOI: 10.1016/S0006-8993(01)03208-5 |
0.56 |
|
| Show low-probability matches. |